Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of dexamethasone and sleep quality in advanced cancer
ACTRN12612000650897Phase 2Completed
- Sponsor
- Mater Misericordiae Health Services Brisbane
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of dexamethasone in sleep disorder and cancer (2 arms), sponsored by Mater Misericordiae Health Services Brisbane. Primary endpoint: Sleep quality. Started Aug 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
sleep disordercancer
Beyond the preview
Go deeper on ACTRN12612000650897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000650897.